$CODA
Coda Octopus Group, Inc. Stock $coda

$coda Overview Financials Valuation SEC Filings Company Website

2024 Q1 Form 10-K Financial Statement

#000149315224004039 Filed on January 29, 2024

Income Statement

Concept	2024 Q1	2023 Q4	2023
Revenue	$4.461M	$3.564M	$19.35M
YoY Change	-20.28%	-30.6%	-12.93%
Cost Of Revenue	$1.374M	$1.274M	$6.321M
YoY Change	-25.43%	-25.0%	-10.15%
Gross Profit	$3.087M	$2.290M	$13.03M
YoY Change	-17.75%	-33.37%	-14.22%
Gross Profit Margin	69.19%	64.25%	67.34%
Selling, General & Admin	$2.045M	$2.056M	$8.195M
YoY Change	4.23%	12.19%	3.1%
% of Gross Profit	66.26%	89.8%	62.89%
Research & Development	$486.0K	$557.8K	$2.096M
YoY Change	9.34%	18.75%	-6.32%
% of Gross Profit	15.74%	24.36%	16.09%
Depreciation & Amortization	$190.5K	$147.5K	$603.5K
YoY Change	16.18%	71.61%	-11.08%
% of Gross Profit	6.17%	6.44%	4.63%
Operating Expenses	$2.531M	$2.614M	$10.29M
YoY Change	5.17%	13.53%	1.03%
Operating Profit	$555.4K	-$324.3K	$2.740M
YoY Change	-58.74%	-128.59%	-45.25%
Interest Expense	$192.5K	$642.5K
YoY Change		-9548.97%
% of Operating Profit	34.67%
Other Income/Expense, Net	$35.02K	-$364.6K	$681.7K
YoY Change	122.14%	-1635.59%	431.43%
Pretax Income	$782.9K	-$46.28K	$3.421M
YoY Change	-42.51%	-104.02%	-33.34%
Income Tax	$153.1K	$274.7K	$297.1K
% Of Pretax Income	19.55%		8.68%
Net Earnings	$629.9K	-$321.0K	$3.124M
YoY Change	-54.94%	-145.59%	-27.37%
Net Earnings / Revenue	14.12%	-9.01%	16.14%
Basic Earnings Per Share	$0.06		$0.28
Diluted Earnings Per Share	$0.06	-$0.03	$0.28
COMMON SHARES
Basic Shares Outstanding	11.16M shares		11.13M shares
Diluted Shares Outstanding	11.26M shares		11.32M shares

Balance Sheet

Concept	2024 Q1	2023 Q4	2023
SHORT-TERM ASSETS
Cash & Short-Term Investments	$25.00M	$24.45M	$24.45M
YoY Change	1.96%	6.64%	6.64%
Cash & Equivalents	$25.00M	$24.45M
Short-Term Investments		$0.00
Other Short-Term Assets	$405.7K	$1.035M	$204.5K
YoY Change	-6.06%	201.59%	-21.09%
Inventory	$12.77M	$11.69M	$11.69M
Prepaid Expenses	$392.6K	$181.4K
Receivables	$3.794M	$2.643M	$3.538M
Other Receivables	$800.5K	$450.6K	$1.012M
Total Short-Term Assets	$42.77M	$40.89M	$40.89M
YoY Change	6.12%	10.48%	10.48%
LONG-TERM ASSETS
Property, Plant & Equipment	$6.340M	$6.873M	$6.873M
YoY Change	4.42%	17.84%	17.84%
Goodwill	$3.382M	$3.382M
YoY Change		0.0%
Intangibles	$496.2K	$486.6K
YoY Change		10.02%
Long-Term Investments
YoY Change
Other Assets	$21.58K	$211.4K	$211.4K
YoY Change	-92.71%	-18.64%	-18.64%
Total Long-Term Assets	$10.24M	$10.95M	$10.95M
YoY Change	0.41%	10.45%	10.45%
TOTAL ASSETS
Total Short-Term Assets	$42.77M	$40.89M	$40.89M
Total Long-Term Assets	$10.24M	$10.95M	$10.95M
Total Assets	$53.01M	$51.84M	$51.84M
YoY Change	4.97%	10.47%	10.47%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.110M	$1.308M	$1.308M
YoY Change	-21.51%	64.92%	64.92%
Accrued Expenses	$856.0K	$384.9K	$995.6K
YoY Change	-46.91%	-77.77%	-42.51%
Deferred Revenue	$786.5K	$975.5K
YoY Change	-2.31%	3.39%
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$2.753M	$3.279M	$3.279M
YoY Change	-28.16%	-5.45%	-5.45%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$110.5K	$133.4K	$133.4K
YoY Change	8.57%	75.2%	75.2%
Total Long-Term Liabilities	$110.5K	$133.4K	$133.4K
YoY Change	8.57%	75.21%	75.2%
TOTAL LIABILITIES
Total Short-Term Liabilities	$2.753M	$3.279M	$3.279M
Total Long-Term Liabilities	$110.5K	$133.4K	$133.4K
Total Liabilities	$2.863M	$3.413M	$3.413M
YoY Change	-27.21%	-3.72%	-3.72%
SHAREHOLDERS EQUITY
Retained Earnings	-$10.42M	-$11.05M
YoY Change	-18.44%	-22.04%
Common Stock	$11.17K	$11.12K
YoY Change	2.03%	-99.98%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$61.93K	$46.30K
YoY Change	118.56%	63.39%
Treasury Stock Shares
Shareholders Equity	$50.15M	$48.43M	$48.43M
YoY Change
Total Liabilities & Shareholders Equity	$53.01M	$51.84M	$51.84M
YoY Change	4.97%	10.47%	10.47%

Cashflow Statement

Concept	2024 Q1	2023 Q4	2023
OPERATING ACTIVITIES
Net Income	$629.9K	-$321.0K	$3.124M
YoY Change	-54.94%	-145.59%	-27.37%
Depreciation, Depletion And Amortization	$190.5K	$147.5K	$603.5K
YoY Change	16.18%	71.61%	-11.08%
Cash From Operating Activities	-$298.0K	$1.010M	$2.390M
YoY Change	-130.25%	127.22%	-64.47%
INVESTING ACTIVITIES
Capital Expenditures	$162.5K	$1.620M	$2.022M
YoY Change	92.46%	153.44%	333.46%
Acquisitions
YoY Change
Other Investing Activities	$771.8K	$609.6K	$609.6K
YoY Change
Cash From Investing Activities	$609.3K	-$1.011M	-$1.521M
YoY Change	-675.34%	-258.1%	173.25%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-15.63K	2.040K	-$17.96K
YoY Change		-107.2%	-80.45%
NET CHANGE
Cash From Operating Activities	-298.0K	1.010M	$2.390M
Cash From Investing Activities	609.3K	-1.011M	-$1.521M
Cash From Financing Activities	-15.63K	2.040K	-$17.96K
Net Change In Cash	295.7K	1.140K	$1.521M
YoY Change	-81.46%	-99.89%	-70.63%
FREE CASH FLOW
Cash From Operating Activities	-$298.0K	$1.010M	$2.390M
Capital Expenditures	$162.5K	$1.620M	$2.022M
Free Cash Flow	-$460.4K	-$610.5K	$367.9K
YoY Change	-151.13%	213.25%	-94.12%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023	dei	Amendment Flag AmendmentFlag	false
CY2023	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2023	dei	Entity Central Index Key EntityCentralIndexKey	0001334325
CY2023Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q4	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2022Q4	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2023Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2023Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2022	us-gaap	Investment Income Nonoperating InvestmentIncomeNonoperating		usd
CY2023	us-gaap	Interest Expense InterestExpense		usd
CY2022	us-gaap	Proceeds From Sale Of Productive Assets ProceedsFromSaleOfProductiveAssets		usd
CY2023	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt		usd
CY2023	us-gaap	Interest Paid Net InterestPaidNet		usd
CY2023	CODA	Purchase Of Property And Equipment Previously Held In Escrow Included In Prepaid Expenses PurchaseOfPropertyAndEquipmentPreviouslyHeldInEscrowIncludedInPrepaidExpenses		usd
CY2022Q4	us-gaap	Other Receivables OtherReceivables		usd
CY2023	CODA	Erc Payroll Tax Credits ERCPayrollTaxCredits		usd
CY2022	us-gaap	Investment Income Nonoperating InvestmentIncomeNonoperating		usd
CY2023	us-gaap	Interest Expense InterestExpense		usd
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross		shares
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
CY2022	CODA	Share Based Compensation Arrangement By Share Based Payment Award Options Vested In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedInPeriodGross		shares
CY2022	CODA	Share Based Compensation Arrangements By Share Based Payment Award Options Vested In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsVestedInPeriodWeightedAverageExercisePrice
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross		shares
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
CY2023	CODA	Share Based Compensation Arrangement By Share Based Payment Award Options Vested In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedInPeriodGross		shares
CY2023	CODA	Share Based Compensation Arrangements By Share Based Payment Award Options Vested In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsVestedInPeriodWeightedAverageExercisePrice
CY2022	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit		usd
CY2022	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit		usd
CY2023Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards Domestic DeferredTaxAssetsOperatingLossCarryforwardsDomestic		usd
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards Domestic DeferredTaxAssetsOperatingLossCarryforwardsDomestic		usd
CY2023Q4	us-gaap	Deferred Tax Assets Deferred Income DeferredTaxAssetsDeferredIncome		usd
CY2022Q4	CODA	Deferred Tax Assets Foreign Capital Loss Carryforwards DeferredTaxAssetsForeignCapitalLossCarryforwards		usd
CY2023Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance		usd
CY2023Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance		usd
CY2023	dei	Document Type DocumentType	10-K
CY2023	dei	Document Annual Report DocumentAnnualReport	true
CY2023	dei	Document Period End Date DocumentPeriodEndDate	2023-10-31
CY2023	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--10-31
CY2023	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023	dei	Document Transition Report DocumentTransitionReport	false
CY2023	dei	Entity File Number EntityFileNumber	001-38154
CY2023	dei	Entity Registrant Name EntityRegistrantName	CODA OCTOPUS GROUP, INC.
CY2023	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2023	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	34-2008348
CY2023	dei	Entity Address Address Line1 EntityAddressAddressLine1	3300 S Hiawassee Rd
CY2023	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 104-105
CY2023	dei	Entity Address City Or Town EntityAddressCityOrTown	Orlando
CY2023	dei	Entity Address State Or Province EntityAddressStateOrProvince	FL
CY2023	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	32835
CY2023	dei	City Area Code CityAreaCode	407
CY2023	dei	Local Phone Number LocalPhoneNumber	735 2406
CY2023	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2023	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2023	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023	dei	Entity Small Business EntitySmallBusiness	true
CY2023	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2023	dei	Document Fin Stmt Error Correction Flag DocumentFinStmtErrorCorrectionFlag	false
CY2023	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Public Float EntityPublicFloat	37700000	usd
CY2024Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	11164483	shares
CY2023	dei	Auditor Firm AuditorFirmId	215
CY2023	dei	Auditor Name AuditorName	Frazier & Deeter
CY2023	dei	Auditor Location AuditorLocation	Atlanta, Georgia
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	24448841	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	22927371	usd
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	2643461	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	2870600	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	11685525	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	10027111	usd
CY2023Q4	us-gaap	Unbilled Receivables Current UnbilledReceivablesCurrent	894251	usd
CY2022Q4	us-gaap	Unbilled Receivables Current UnbilledReceivablesCurrent	602115	usd
CY2023Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	181383	usd
CY2022Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	240464	usd
CY2023Q4	us-gaap	Other Assets Current OtherAssetsCurrent	1034626	usd
CY2022Q4	us-gaap	Other Assets Current OtherAssetsCurrent	343061	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	40888087	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	37010722	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	6873320	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	5832532	usd
CY2023Q4	us-gaap	Goodwill Goodwill	3382108	usd
CY2022Q4	us-gaap	Goodwill Goodwill	3382108	usd
CY2023Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	486615	usd
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	442286	usd
CY2023Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	211386	usd
CY2022Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	259810	usd
CY2023Q4	us-gaap	Other Assets OtherAssets	4080109	usd
CY2022Q4	us-gaap	Other Assets OtherAssets	4084204	usd
CY2023Q4	us-gaap	Assets Assets	51841516	usd
CY2022Q4	us-gaap	Assets Assets	46927458	usd
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	1308201	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	793247	usd
CY2023Q4	us-gaap	Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent	995630	usd
CY2022Q4	us-gaap	Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent	1731706	usd
CY2023Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	975537	usd
CY2022Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	943569	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	3279368	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	3468522	usd
CY2023Q4	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	133382	usd
CY2022Q4	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	76127	usd
CY2023Q4	us-gaap	Liabilities Liabilities	3412750	usd
CY2022Q4	us-gaap	Liabilities Liabilities	3544649	usd
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	150000000	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	150000000	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	11117695	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	11117695	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	10916853	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	10916853	shares
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	11118	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	10918	usd
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2023Q4	us-gaap	Treasury Stock Value TreasuryStockValue	46300	usd
CY2022Q4	us-gaap	Treasury Stock Value TreasuryStockValue	28337	usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	62958984	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	62313988	usd
CY2023Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-3442549	usd
CY2022Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-4737124	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-11052487	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-14176636	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	48428766	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	43382809	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	51841516	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	46927458	usd
CY2023	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	19352088	usd
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	22225803	usd
CY2023	us-gaap	Cost Of Revenue CostOfRevenue	6321033	usd
CY2022	us-gaap	Cost Of Revenue CostOfRevenue	7035115	usd
CY2023	us-gaap	Gross Profit GrossProfit	13031055	usd
CY2022	us-gaap	Gross Profit GrossProfit	15190688	usd
CY2023	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2096467	usd
CY2022	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2237920	usd
CY2023	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	8195036	usd
CY2022	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	7948704	usd
CY2023	us-gaap	Operating Expenses OperatingExpenses	10291503	usd
CY2022	us-gaap	Operating Expenses OperatingExpenses	10186624	usd
CY2023	us-gaap	Operating Income Loss OperatingIncomeLoss	2739552	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	5004064	usd
CY2023	us-gaap	Other Income OtherIncome	39146	usd
CY2022	us-gaap	Other Income OtherIncome	137975	usd
CY2023	us-gaap	Investment Income Nonoperating InvestmentIncomeNonoperating	642530	usd
CY2022	us-gaap	Interest Expense InterestExpense	9704	usd
CY2023	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	681676	usd
CY2022	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	128271	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	3421228	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	5132335	usd
CY2023	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	248655	usd
CY2022	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	1005140	usd
CY2023	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	48424	usd
CY2022	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-174026	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	297079	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	831114	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	3124149	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	4301221	usd
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.28
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.40
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.28
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.38
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	11131469	shares
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	10863674	shares
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	11323568	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	11281347	shares
CY2023	us-gaap	Net Income Loss NetIncomeLoss	3124149	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	4301221	usd
CY2023	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	1294575	usd
CY2022	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-3070065	usd
CY2023	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	1294575	usd
CY2022	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-3070065	usd
CY2023	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	4418724	usd
CY2022	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	1231156	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	41049073	usd
CY2022	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1130917	usd
CY2022	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	-28337	usd
CY2022	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-3070065	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	4301221	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	43382809	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	43382809	usd
CY2023	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	645196	usd
CY2023	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	-17963	usd
CY2023	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	1294575	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	3124149	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	48428766	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	48428766	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	3124149	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	4301221	usd
CY2023	us-gaap	Depreciation And Amortization DepreciationAndAmortization	603467	usd
CY2022	us-gaap	Depreciation And Amortization DepreciationAndAmortization	678652	usd
CY2023	us-gaap	Adjustment For Amortization AdjustmentForAmortization	64063	usd
CY2022	us-gaap	Adjustment For Amortization AdjustmentForAmortization	60077	usd
CY2023	us-gaap	Share Based Compensation ShareBasedCompensation	645196	usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	1130917	usd
CY2023	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	48726	usd
CY2022	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	-193083	usd
CY2023	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-291873	usd
CY2022	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-992948	usd
CY2023	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	1287108	usd
CY2022	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	675878	usd
CY2023	us-gaap	Increase Decrease In Contract With Customer Asset IncreaseDecreaseInContractWithCustomerAsset	281981	usd
CY2022	us-gaap	Increase Decrease In Contract With Customer Asset IncreaseDecreaseInContractWithCustomerAsset	-447927	usd
CY2023	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-68836	usd
CY2022	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-165010	usd
CY2023	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	330516	usd
CY2022	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	-275909	usd
CY2023	us-gaap	Increase Decrease In Accounts Payable And Other Operating Liabilities IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities	-613239	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable And Other Operating Liabilities IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities	533996	usd
CY2023	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	56410	usd
CY2022	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-990729	usd
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	2389876	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	6726967	usd
CY2023	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	2021948	usd
CY2022	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	466471	usd
CY2023	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	108392	usd
CY2022	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	90089	usd
CY2023	us-gaap	Proceeds From Sale Of Productive Assets ProceedsFromSaleOfProductiveAssets	609565	usd
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1520775	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-556560	usd
CY2022	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	63559	usd
CY2023	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	17963	usd
CY2022	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	28337	usd
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-17963	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-91896	usd
CY2023	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	670332	usd
CY2022	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	-898796	usd
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	1521470	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	5179715	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	22927371	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	17747656	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	24448841	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	22927371	usd
CY2022	us-gaap	Interest Paid Net InterestPaidNet	9704	usd
CY2023	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	1406562	usd
CY2022	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	74432	usd
CY2022	CODA	Purchase Of Property And Equipment Previously Held In Escrow Included In Prepaid Expenses PurchaseOfPropertyAndEquipmentPreviouslyHeldInEscrowIncludedInPrepaidExpenses	694664	usd
CY2023	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_84D_eus-gaap--UseOfEstimates_z1gGS6l13Eal" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_86A_zcqK3N3wt5Yk">Estimates</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes. The accounting estimates and assumptions that require management’s most significant, challenging, and subjective judgment include estimates related to the percentage of completion method used to account for contracts including costs and earnings in excess of billings, billings in excess of costs and estimated earnings, the valuation of the deferred tax asset, and the valuation of goodwill. Actual results realized by the Company may differ from management’s estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2023	CODA	Cost Of Revenue Commissions CostOfRevenueCommissions	826719	usd
CY2022	CODA	Cost Of Revenue Commissions CostOfRevenueCommissions	631471	usd
CY2023	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-190073	usd
CY2022	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	431314	usd
CY2023Q4	us-gaap	Deposits Assets Current DepositsAssetsCurrent	23081	usd
CY2022Q4	us-gaap	Deposits Assets Current DepositsAssetsCurrent	18631	usd
CY2023Q4	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	450625	usd
CY2022Q4	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	151217	usd
CY2023Q4	us-gaap	Cash Fdic Insured Amount CashFDICInsuredAmount	23300000	usd
CY2023Q4	CODA	Employee Retention Credit Receivables EmployeeRetentionCreditReceivables	212300	usd
CY2022Q4	CODA	Employee Retention Credit Receivables EmployeeRetentionCreditReceivables	173213	usd
CY2023Q4	us-gaap	Other Receivables OtherReceivables	348620	usd
CY2023Q4	us-gaap	Other Assets Current OtherAssetsCurrent	1034626	usd
CY2022Q4	us-gaap	Other Assets Current OtherAssetsCurrent	343061	usd
CY2023Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	0	usd
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	2643461	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	2870600	usd
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	4207996	usd
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	0	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	0	usd
CY2021Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	0	usd
CY2023	us-gaap	Finite Lived Intangible Assets Amortization Method FiniteLivedIntangibleAssetsAmortizationMethod	The Company’s intangible assets are amortized on a straight-line basis over their estimated useful lives, ranging from 2 to 15 years.
CY2023Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	975537	usd
CY2023Q4	CODA	Depreciation Cost Of Goods Sold Allocation Percentage DepreciationCostOfGoodsSoldAllocationPercentage	0.70	pure
CY2023Q4	CODA	Depreciation Of General And Administration Expense Percentage DepreciationOfGeneralAndAdministrationExpensePercentage	0.30	pure
CY2023	us-gaap	Advertising Expense AdvertisingExpense	0	usd
CY2022	us-gaap	Advertising Expense AdvertisingExpense	0	usd
CY2023Q4	us-gaap	Unbilled Receivables Current UnbilledReceivablesCurrent	894251	usd
CY2022Q4	us-gaap	Unbilled Receivables Current UnbilledReceivablesCurrent	602115	usd
CY2023Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	975537	usd
CY2022Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	943569	usd
CY2022Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	943569	usd
CY2021Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	1999841	usd
CY2023Q4	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	133382	usd
CY2022Q4	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	76127	usd
CY2022Q4	us-gaap	Goodwill Goodwill	3382108	usd
CY2023Q4	us-gaap	Marketable Securities MarketableSecurities	0	usd
CY2022Q4	us-gaap	Marketable Securities MarketableSecurities	0	usd
CY2023	CODA	Interest Bearing Deposits Current Rate InterestBearingDepositsCurrentRate	0.050	pure
CY2023Q4	us-gaap	Inventory Raw Materials And Supplies InventoryRawMaterialsAndSupplies	8994482	usd
CY2022Q4	us-gaap	Inventory Raw Materials And Supplies InventoryRawMaterialsAndSupplies	7219344	usd
CY2023Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	483227	usd
CY2022Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	383427	usd
CY2023Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	2207816	usd
CY2022Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	2424340	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	11685525	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	10027111	usd
CY2023Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	11678346	usd
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	10537055	usd
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	4805026	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	4704523	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	6873320	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	5832532	usd
CY2023	us-gaap	Depreciation Depreciation	603467	usd
CY2022	us-gaap	Depreciation Depreciation	678652	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	6873320	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	5832532	usd
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	384880	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1474744	usd
CY2023Q4	CODA	Other Tax Payables Receivables OtherTaxPayablesReceivables	525565	usd
CY2022Q4	CODA	Other Tax Payables Receivables OtherTaxPayablesReceivables	144158	usd
CY2023Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	85185	usd
CY2022Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	112804	usd
CY2023Q4	us-gaap	Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent	995630	usd
CY2022Q4	us-gaap	Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent	1731706	usd
CY2021Q4	CODA	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingNonvestedNumber	122000	shares
CY2021Q4	CODA	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Outstanding Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedOutstandingWeightedAverageGrantDateFairValue	8.80
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	122000	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	8.80
CY2022	CODA	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingGrantsInPeriod	64687	shares
CY2022	CODA	Erc Payroll Tax Credits ERCPayrollTaxCredits	88917	usd
CY2023	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	39146	usd
CY2022	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	49058	usd
CY2023	us-gaap	Other Income OtherIncome	39146	usd
CY2022	us-gaap	Other Income OtherIncome	137975	usd
CY2023	us-gaap	Investment Income Nonoperating InvestmentIncomeNonoperating	642530	usd
CY2022	us-gaap	Interest Expense InterestExpense	9704	usd
CY2023	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	681676	usd
CY2022	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	128271	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	1700153	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	-1213538	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	486615	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	1589254	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	-1146968	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	442286	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	56104	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	42514	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	39434	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	36657	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	311906	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	486615	usd
CY2023	us-gaap	Adjustment For Amortization AdjustmentForAmortization	64063	usd
CY2022	us-gaap	Adjustment For Amortization AdjustmentForAmortization	60077	usd
CY2023Q4	us-gaap	Goodwill Goodwill	3382108	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	3124149	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	4301221	usd
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	11131469	shares
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	10863674	shares
CY2023	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	192099	shares
CY2022	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	417673	shares
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	11323568	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	11281347	shares
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.28
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.40
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.28
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.38
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	383668	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	4.65
CY2022	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	36667	shares
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	4.65
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	39834	shares
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	4.65
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	307167	shares
CY2023	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	199496	shares
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	4.62
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	3000	shares
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	6.23
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	104671	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	4.67
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P1Y4M28D
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	202419	usd
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber	104671	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice	4.67
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1	P1Y4M28D
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue	202419	usd
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	104671	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	4.67
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P1Y4M28D
CY2023Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	202419	usd
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	104671	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	4.67
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	104671	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice	4.67
CY2022	CODA	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Outstanding Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodOutstandingWeightedAverageGrantDateFairValue	7.15
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod	64687	shares
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	7.15
CY2022	CODA	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Vested In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingVestedInPeriod	-53733	shares
CY2022	CODA	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Outstanding Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodOutstandingWeightedAverageGrantDateFairValue	5.05
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod	53733	shares
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue	5.05
CY2022	CODA	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Treasury Stockin Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingTreasuryStockinPeriod	5467	shares
CY2022	CODA	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Treasury Stock Outstanding Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsTreasuryStockOutstandingWeightedAverageGrantDateFairValue	5.18
CY2022	CODA	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Treasury Stock In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsTreasuryStockInPeriod	5467	shares
CY2022	CODA	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Treasury Stock Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsTreasuryStockWeightedAverageGrantDateFairValue	5.18
CY2022	CODA	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Forfeited In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingForfeitedInPeriod	16981	shares
CY2022	CODA	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Outstanding Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresOutstandingWeightedAverageGrantDateFairValue	8.43
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod	16981	shares
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue	8.43
CY2022Q4	CODA	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingNonvestedNumber	110506	shares
CY2022Q4	CODA	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Outstanding Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedOutstandingWeightedAverageGrantDateFairValue	8.10
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	110506	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	8.10
CY2023	CODA	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingGrantsInPeriod	100428	shares
CY2023	CODA	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Outstanding Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodOutstandingWeightedAverageGrantDateFairValue	7.10
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod	98546	shares
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	6.96
CY2023	CODA	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Vested In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingVestedInPeriod	-108568	shares
CY2023	CODA	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Outstanding Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodOutstandingWeightedAverageGrantDateFairValue	7.91
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod	108568	shares
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue	7.91
CY2023	CODA	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Treasury Stockin Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingTreasuryStockinPeriod	1932	shares
CY2023	CODA	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Treasury Stock Outstanding Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsTreasuryStockOutstandingWeightedAverageGrantDateFairValue	9.30
CY2023	CODA	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Treasury Stock In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsTreasuryStockInPeriod	1932	shares
CY2023	CODA	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Treasury Stock Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsTreasuryStockWeightedAverageGrantDateFairValue	9.30
CY2023	CODA	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Forfeited In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingForfeitedInPeriod	13006	shares
CY2023	CODA	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Outstanding Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresOutstandingWeightedAverageGrantDateFairValue	5.77
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod	13006	shares
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue	5.77
CY2023Q4	CODA	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingNonvestedNumber	87428	shares
CY2023Q4	CODA	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Outstanding Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedOutstandingWeightedAverageGrantDateFairValue	7.04
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	85546	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	7.04
CY2023Q4	us-gaap	Deferred Compensation Liability Current DeferredCompensationLiabilityCurrent	154539	usd
CY2023Q4	CODA	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingNonvestedNumber	87428	shares
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2022Q4	CODA	Deferred Tax Asset Restricted Stock Awards DeferredTaxAssetRestrictedStockAwards	272841	usd
CY2023Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	-21554	usd
CY2022Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	-17861	usd
CY2023Q4	CODA	Deferred Tax Assets Foreign Research And Development Refunds DeferredTaxAssetsForeignResearchAndDevelopmentRefunds	-218045	usd
CY2022Q4	CODA	Deferred Tax Assets Foreign Research And Development Refunds DeferredTaxAssetsForeignResearchAndDevelopmentRefunds	-84381	usd
CY2023Q4	CODA	Deferred Tax Assets Foreign Capital Loss Carryforwards DeferredTaxAssetsForeignCapitalLossCarryforwards	11182	usd
CY2023Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards Foreign DeferredTaxAssetsOperatingLossCarryforwardsForeign	176585	usd
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards Foreign DeferredTaxAssetsOperatingLossCarryforwardsForeign	409100	usd
CY2023Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	211386	usd
CY2022Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	584529	usd
CY2023	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	264955	usd
CY2022	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	849580	usd
CY2023	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	5789	usd
CY2022	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	159900	usd
CY2023	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	-22089	usd
CY2022	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	-4340	usd
CY2023	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	248655	usd
CY2022	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	1005140	usd
CY2023	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	14941	usd
CY2022	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-174026	usd
CY2023	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	3913	usd
CY2023	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	29570	usd
CY2023	us-gaap	Deferred Other Tax Expense Benefit DeferredOtherTaxExpenseBenefit	48424	usd
CY2022	us-gaap	Deferred Other Tax Expense Benefit DeferredOtherTaxExpenseBenefit	-174026	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	297079	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	831114	usd
CY2023	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Research And Development EffectiveIncomeTaxRateReconciliationNondeductibleExpenseResearchAndDevelopment	0.097	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Research And Development EffectiveIncomeTaxRateReconciliationNondeductibleExpenseResearchAndDevelopment	0.106	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	0.034	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.037	pure
CY2023	CODA	Effective Income Tax Rate Reconciliation Foreign Tax Benefit Including Gilti Net EffectiveIncomeTaxRateReconciliationForeignTaxBenefitIncludingGiltiNet	0.021	pure
CY2022	CODA	Effective Income Tax Rate Reconciliation Foreign Tax Benefit Including Gilti Net EffectiveIncomeTaxRateReconciliationForeignTaxBenefitIncludingGiltiNet	-0.009	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.013	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	-0.030	pure
CY2023	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.087	pure
CY2022	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.162	pure
CY2022Q4	us-gaap	Deferred Tax Assets Deferred Income DeferredTaxAssetsDeferredIncome	4830	usd
CY2023Q4	CODA	Deferred Tax Asset Restricted Stock Awards DeferredTaxAssetRestrictedStockAwards	263218	usd
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	324719	usd
CY2023Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	211386	usd
CY2022Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	259810	usd
CY2023	CODA	Research And Development Tax Expenses ResearchAndDevelopmentTaxExpenses	174771	gbp
CY2023	CODA	Research And Development Tax Expenses ResearchAndDevelopmentTaxExpenses	158883	usd
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	324719	usd
CY2019Q4	us-gaap	Line Of Credit Facility Maximum Borrowing Capacity LineOfCreditFacilityMaximumBorrowingCapacity	4000000	usd
CY2023	us-gaap	Line Of Credit Facility Maximum Amount Outstanding During Period LineOfCreditFacilityMaximumAmountOutstandingDuringPeriod	0	usd
CY2022	us-gaap	Line Of Credit Facility Maximum Amount Outstanding During Period LineOfCreditFacilityMaximumAmountOutstandingDuringPeriod	0	usd
CY2023	CODA	Employee Compensation Percentage EmployeeCompensationPercentage	0.04	pure
CY2023	us-gaap	Defined Benefit Plan Service Cost DefinedBenefitPlanServiceCost	128988	usd
CY2022	us-gaap	Defined Benefit Plan Service Cost DefinedBenefitPlanServiceCost	138260	usd
CY2023	us-gaap	Revenues Revenues	19352088	usd
CY2023	us-gaap	Revenues Revenues	19352088	usd
CY2023	us-gaap	Revenues Revenues	19352088	usd
CY2022	us-gaap	Revenues Revenues	22225803	usd
CY2022	us-gaap	Revenues Revenues	22225803	usd
CY2022	us-gaap	Revenues Revenues	22225803	usd

Files In Submission

Name	View Source	Status
coda-20231031_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
0001493152-24-004039-index-headers.html	Edgar Link	pending
0001493152-24-004039-index.html	Edgar Link	pending
0001493152-24-004039.txt	Edgar Link	pending
0001493152-24-004039-xbrl.zip	Edgar Link	pending
coda-20231031.xsd	Edgar Link	pending
ex23-1.htm	Edgar Link	pending
ex31-1.htm	Edgar Link	pending
ex32.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
form10-k.htm	Edgar Link	pending
form10-k_001.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
coda-20231031_lab.xml	Edgar Link	unprocessable
coda-20231031_def.xml	Edgar Link	unprocessable
coda-20231031_cal.xml	Edgar Link	unprocessable
form10-k_htm.xml	Edgar Link	completed
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$CODA
Coda Octopus Group, Inc. Stock $coda

2024 Q1 Form 10-K Financial Statement

#000149315224004039 Filed on January 29, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CODA Coda Octopus Group, Inc. Stock $coda

2024 Q1 Form 10-K Financial Statement

#000149315224004039 Filed on January 29, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CODA
Coda Octopus Group, Inc. Stock $coda